PARICALCITOL and SEPSIS

Overview

SEPSIS is the #4 most commonly reported adverse reaction for PARICALCITOL, manufactured by AbbVie Inc.. There are 483 FDA adverse event reports linking PARICALCITOL to SEPSIS. This represents approximately 2.5% of all 19,271 adverse event reports for this drug.

Patients taking PARICALCITOL who experience sepsis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

SEPSIS is a less commonly reported adverse event for PARICALCITOL, but still significant enough to appear in the safety profile.

Other Side Effects of PARICALCITOL

In addition to sepsis, the following adverse reactions have been reported for PARICALCITOL:

• DEATH — 3,570 reports
• CARDIAC DISORDER — 621 reports
• MYOCARDIAL INFARCTION — 584 reports
• CARDIO RESPIRATORY ARREST — 476 reports
• DYSPNOEA — 393 reports
• CARDIAC FAILURE — 349 reports
• RENAL FAILURE — 308 reports
• PNEUMONIA — 301 reports
• NAUSEA — 299 reports
• CEREBROVASCULAR ACCIDENT — 285 reports

Other Drugs Associated with SEPSIS

The following drugs have also been linked to sepsis in FDA adverse event reports:

Does PARICALCITOL cause SEPSIS?

SEPSIS has been reported as an adverse event in 483 FDA reports for PARICALCITOL. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is SEPSIS with PARICALCITOL?

SEPSIS accounts for approximately 2.5% of all adverse event reports for PARICALCITOL, making it a notable side effect.

What should I do if I experience SEPSIS while taking PARICALCITOL?

If you experience sepsis while taking PARICALCITOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages